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Background: In traditional Chinese medicine (TCM) clinical practice, ZHENG (also known as TCM syndrome) helps
to understand the human homeostasis and guide individualized treatment. However, the scientific basis of ZHENG
remains unclear due to limitations of current reductionist approaches.
Methods: We collected the leukocyte samples of three hepatitis B-caused cirrhosis (HBC) patients with
dampness-heat accumulation syndrome (DHAS) and three HBC patients with liver depression and spleen deficiency
syndrome (LDSDS) for microarray analysis. We generated Gene-Regulatory-Networks (GeneRelNet) from the
differentially expressed genes (DEGs) of microarray date. Core genes were validated using anther independent
cohort of 40 HBC patients (20 DHAS, 20 LDSDS) with RT-PCR.
Results: There were 2457 mapped genes were differentially expressed between DHAS and LDSDS (Fold change ≥ 2.0,
P < 0.05). There were markedly different genes co-expression patterns in DHAS and LDSDS. Furthermore, three
differential co-expression genes including purine nucleoside phosphorylase (PNP); aquaporin 7 (AQP7) and
proteasome 26S subunit, non-ATPase 2 (PSMD2) were screened by GeneRelNets, and their mRNA expressions
were further validated by real time RT-PCR. The results were consistent with microarray. The PNP (P = 0.007),
AQP7 (P = 0.038) and PSMD2 (P = 0.009) mRNA expression is significant difference between DHAS and LDSDS
using the non-parametric test. Furthermore, we constructed an mRNA panel of PNP, AQP7 and PSMD2 (PAP panel)
by logistic regression model, and evaluated the PAP panel to distinguish DHAS from LDSDS by area under the receiver
operating characteristic curve (AUC) analysis, which showed a higher accuracy (AUC = 0.835). Gene ontology (GO)
analysis indicated that the DHAS is most likely related to system process while the functions overrepresented by LDSDS
most related to the response to stimulus.
Conclusions: This study suggested that there are particular transcriptional profiles, genes co-expressions patterns and
functional properties of DHAS and LDSDS, and PNP, AQP7, and PSMD2 may be involved in ZHENG differentiation of
DHAS and LDSDS in HBC.
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Chronic hepatitis B virus (HBV) infection is a serious
health problem because its worldwide distribution and
it has potential adverse sequelae such as cirrhosis and
hepatocellular carcinoma (HCC) [1,2]. It was estimated
that more than 200,000 chronic HBV carriers die of liver
cirrhosis each year globally [3]. Since HBV replication
may persist after the development of chronic hepatitis B
(CHB) [2], hepatitis B-caused cirrhosis (HBC) is easily
happen. Moreover, HBC increases the risk of developing
HCC by at least 40 times over the risk of an average
person [4].
Traditional Chinese medicine (TCM) is extensively used
for treatment of liver disease in China, with the great advan-
tages in early intervention, combination therapies, personal-
ized medicine, etc. TCM treatment is based on ZHENG
(also known as TCM syndrome) differentiation, namely,
discerning patterns of imbalances within the body and be-
tween the body and the environment by the analysis of
symptoms and signs of patients. It is the key principle of
TCM. Since ZHENG differentiation depended on clinical
observation and TCM practitioner’s experience, it would
be subjective and unrepeatable. The phenotype-oriented
diagnosis and therapy in TCM needs to be objective and
quantified evaluation for the inheritance [5].
TCM has long been practiced as an empirical and hol-
istic medicine, which happens to share the same concept
with the systems biological medicine. The advent of
high-throughput technologies, such as transcript micro-
array chips, has allowed simultaneous interrogation of mul-
tiple molecular components at any given time. Advances in
gene expression profiling have been used to identify key
differentially expressed genes (DEGs) and pathways in
HBV-related patients with different ZHENGs. In the pre-
vious study, we reported that the molecular mechanism of
“same TCM syndrome for different diseases and different
TCM syndrome for same disease” [6]. Besides, we inte-
grated the CHB gene expression with topological features
of different ZHENGs resulted in enhanced diagnosis of
CHB. The miRNA-target network analysis elucidated
dysfunctional interactions among genes and miRNAs-
target genes of three different ZHENGs [7]. Above all,
the transcriptional profiles of ZHENG differentiation
in HBC could be interpreted using the systems-omics
approach.
The dampness-heat accumulation syndrome (DHAS)
and the liver depression and spleen deficiency syndrome
(LDSDS) are the major ZHENGs in HBC [8]. In this
study, we demonstrated that the transcriptional profiles
and the functional properties are significantly different
in DHAS and LDSDS. Besides, the differential expression
or co-expression genes could be the potential biomarkers
for ZHENG differentiation with DHAS and LDSDS in
HBC patients.Methods
Samples and RNA extraction
Morning fasting venous blood samples of total 46 HBC
patients (23 DHAS, 23 LDSDS) were obtained from Shu-
guang Hospital and Longhua Hospital in Shanghai,
China. Six HBC patients (3 DHAS, 3 LDSDS) were used
for microarray analysis. Another independent cohort of
40 HBC patients (20 DHAS, 20 LDSDS) was used as val-
idation group. The research protocol was approved by
the respective institutional review boards, and informed
consent was obtained for all study participants. The
study was approved by the Official Ethics Committee of
the Shanghai University of TCM and written informed
consent to participate in the study was obtained from all
subjects included. Diagnosis standard of cirrhosis is re-
ferred to “Chronic hepatitis B prevention and treatment
guidelines” [9]. The TCM ZHENG types were identified
by three chief or deputy physicians, according to “evalu-
ation criteria of the clinical diagnosis, drug efficacy, and
ZHENG differentiation for cirrhosis (pilot program)” [8].
All the outpatients were diagnosed by attending TCM
physicians at the first time and then identified by three
chief TCM physicians, who were consistently diagnosed
as DHAS or LDSDS by all of the physicians were enrolled
in this study [10,11]. The patients with other hepatotropic
virus hepatitis, chronic severe hepatitis, serious primary
disease or pregnancy were excluded. The exclusion criter-
ion of HBC: (1) cases complicated with other hepatotropic
virus; (2) age < 18 or age > 65; (3) associated with serious
primary disease of heart, kidney, lung, endocrine, blood,
metabolic and gastrointestinal; (4) psychotic patients; (5)
pregnant or lactating women. Samples of three DHAS,
three LDSDS and three normal control were used to
microarray detection. Another independent twenty DHAS
and twenty LDSDS in HBC patients were used to verify
the accuracy of the results. The characteristics of the study
participants are presented in Table 1. The leukocyte from
blood samples were isolated with Ficoll optimized density
gradient separation [12] and saved at −80°C.
Total RNA was extracted using a “two-step” protocol
as described previously [6]. Total RNA of leukocyte from
the whole blood was extracted using TRIzol® Reagent
(Invitrogen, Carlsbad, CA, US) and saved at −80°C. A
Quality Control was carried out with NanoDrop ND-
1000.
Microarrays and data analysis
The biotinylated cDNAs were hybridized to NimbleGen
Homo sapiens 12 × 135K Array (Roche, CAT No. A6484-
00-01). This product analyzes the expression level for
over 135,000 transcripts and variants, including 44049
well-substantiated human genes.
Microarray data preprocessing was performed using
the Gene-Pix software. Raw expression data were log2
Table 1 Clinical parameters of subjects
Characteristics DHAS (mean ± SD) LDSDS (mean ± SD)
n = 46 23 23
Age (years) 53.2 ± 8.1 52.9 ± 6.7
Gender (male) 13 15
ALT (U/L) 33.8 ± 14.8 33.2 ± 18.0
AST (U/L) 42.6 ± 29.7 54.1 ± 39.6
AFP (ng/mL) 7.3 ± 5.9 9.6 ± 10.0
HA (UG/L) 124.3 ± 121.3 152.1 ± 126.8
TBIL (μmol/L) 20.1 ± 11.4 25.4 ± 16.3
DBIL (μmol/L) 4.1 ± 4.4 6.6 ± 6.1
GGT (IU/L) 48.9 ± 28.9 52.0 ± 30.5
ALb (g/L) 41.0 ± 8.0 41.0 ± 6.1
Lu et al. BMC Complementary and Alternative Medicine 2014, 14:371 Page 3 of 9
http://www.biomedcentral.com/1472-6882/14/371transformed and normalized by quantile normalization.
Probes were considered robustly expressed if Signal/Noise
(SNR) > 2.
The t-test function in R software was used to select differ-
ence expressed gene (threshold: P value < 0.05) in ZHENGs
of DHAS and LDSDS. They were both compared with nor-
mal control. Heatmap analysis which executed in Cluster
3.0 was computing the hierarchical clustering in both rows
and columns according to the set of gene values and draw-
ing a color image as a visible result. Gene Ontology (GO)
was analyzed using a DAVID online analysis tool (http://
david.abcc.ncifcrf.gov).
We used a stepwise logistic regression model to combine
diagnostic mRNA markers based on the data obtained by
qRT-PCR. The predicted probability of distinguishing of
DHAS and LDSDS was used as a surrogate marker to con-
struct a receiver operating characteristic (ROC) curve. The
AUC was used as an accuracy index for evaluating the
diagnostic performance of the selected mRNA panel. All
tests were two-tailed and P < 0.05 was considered statisti-
cally significant.
Gene-Regulatory-Networks (GeneRelNet) construction
GeneRelNets [13] were presented to find the interactions
among genes, indicating the gene co-expression relation-
ship. GeneRelNets was constructed by DEGs that ob-
tained by comparing the DHAS or LDSDS. They were
built according to the normalized signal intensity of spe-
cific expression genes. For each pair of genes, we calcu-
late the Pearson correlation and choose the significant
correlation pairs to construct the network.
In network analysis, Degree centrality, Clustering coeffi-
cient and Core genes were analyzed. Degree centrality, de-
fined as the link numbers one node has to the other, is the
most simplest and important measures of the centrality of
a gene within a network that determine the relative im-
portance [14]. Clustering coefficient is a measure of de-
gree to which nodes in a graph tend to cluster together.The higher clustering coefficient of an individual gene, the
higher is the affection among its neighbor genes [15]. The
purpose of network structure analysis of each ZHENG is
to locate differential co-expression genes, which connect
most adjacent genes and have biggest degrees with high
Clustering coefficient. While considering different net-
works, the Core genes were determined by the degree dif-
ferences between two class samples [16]. They always own
the biggest degree differences and selected from the lo-
cated differential co-expression genes.
Real-time RT-PCR
The cDNAs were synthesized by the Invitrogen First-Strand
cDNA Synthesis kits (Invitrogen, Carlsbad, CA, US). Sam-
ples will be qualified for further processing if the A260/
A280 spectrophotometeric ratio is between 1.8 and 2.1.
One μg of total RNA was transcribed into cDNA in a
20 μL reaction volume.
Real-time RT-PCR was used to verify the differential
expression of three genes that detected by the Nimble-
Gen GeneChip. The primers used are listed in Table 2.
Each real-time RT-PCR reaction (in 25 μL) contained
2 × SYBR Green Real-time RT-PCR Master Mix, 0.4 μM
primers, and 0.5 μL of template cDNA. The cycling con-
ditions consisted of an initial, single cycle of 5 min at
95°C, followed by 40 cycles of 30 sec at 95°C, 30 sec at
54°C, 15 sec at 72°C, and fluorescence acquisition at 83°C
for 1 sec. The cDNA was synthesized using reverse tran-
scriptase (TOYOBO, Osaka, Japan), oligo (dT) and ran-
dom primers with 5 μg RNA from the same samples as
those used in the microarray. The PCR amplifications
were performed in duplicate for each sample. The gene
expression levels were quantified relative to the expression
of β-actin by employing an optimized comparative Ct
(ΔΔCt) value method. The differences in gene expression
levels between groups were compared using the Student's
t-test. A p value < 0.05 was considered significant.
Results
Identification of core genes of DHAS and LDSDS in HBC
We analyze the DEGs of DHAS and LDSDS from the
microarrays data. Both samples from DHAS and LDSDS
patients were compared with normal controls and then
compared to each other for the array analysis. DEGs were
defined as |foldchange | ≥ 2, p < 0.05. 3133 genes were
identified after comparison of DHAS and normal control.
3627 genes were identified after comparison of LDSDS and
normal control. Then the DHAS group compared with
LDSDS group. After the two steps of DEGs selection, a
total of 2457 mapped genes were identified to be differen-
tially expressed in DHAS compared to LDSDS with |fold-
change (DHAS/LDSDS) | ≥ 2, p < 0.05. (Figure 1), among
which 1855 genes were up-regulated and 602 genes were
down-regulated.
Table 2 Validated genes and their primer sequences by real-time RT-PCR
Gene symbol Genebank Forward primer Reverse primer
PNP (purine nucleoside phosphorylase) NM_000270 GAGCCCGTGCCCTACCACAC GCAGAACTGAGCCCCTCGGAA
AQP7 (aquaporin 7) NM_001170 TGAGAAGCCCCCAAGGCGGA GCCTGTGCCCGGATGCTTGA
PSMD2 (proteasome 26S subunit, non-ATPase 2) NM_002808 TGCGGCCATTGCCAGTGTCT GTTCCCCGTGGGCCAACAACA
ACTB (β-actin) NM_001101.3 ACAGAGCCTCGCCTTTGCCG ACATGCCGGAGCCGTTGTCG
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file 1), GeneRelNets were constructed, respectively (Figure 2).
The structure of GeneRelNet reflects the situation of
genes co-expressions, which is interaction among genes.
There were markedly different genes co-expression pat-
terns in DHAS and LDSDS (Figure 2). Furthermore, the
genes co-expressions analysis was used to screen the can-
didate genes that may involve in the differentiation of
DHAS and LDSDS.
In network analysis, the differential co-expressed genes
with higher Degree Centrality (degree ≥ 10) and higher
Clustering Coefficient (Clustering Coefficient ≥ 0. 2) were
considered to have important regulation and control
ability. They were located from GeneRelNet of DHAS
or LDSDS for ZHENG differentiation. Core genes in
DHAS and LDSDS had higher degree differences
(ΔDegree) (Figure 3). In this study, the differential co-Figure 1 Hierarchical clustering of DEGs. DEGs of DHAS vs. LDSDS obta
An unsupervised hierarchical clustering of DEGs of DHAS and LDSDS show
Log ratio scale bar for the Treeview color change was also shown.expression genes were defined with ΔDegree ≥ 8. Core
genes were PNP (ΔDegree, 16), AQP7 (ΔDegree, 9), NFE2
(ΔDegree, 9) and PSMD2 (ΔDegree, 8) (Table 3).
Since PNP and AQP7 were the top differential co-
expression genes, and PSMD2 had the highest Degree in
both DHAS and LDSDS. They were chosen to verify the
transcript expressions and compare the difference be-
tween DHAS and LDSDS in HBC.
Validation of core genes in DHAS and LDSDS
GeneRelNets
Following the computational analyses of GeneRelNets,
quantitative RT-PCR was carried out using a cohort of in-
dependent samples of DHAS (n = 20) and LDSDS (n = 20)
in HBC. The expression result of PNP, AQP7 and PSMD2
was consistent with the results from microarrays. At the
transcript expression level, statistical significance wasined after comparing DHAS/normal control and LDSDS/normal control.
ing significantly differential expression revealed two distinct clusters.
Figure 2 DHAS and LDSDS GenRelNets. Left is DHAS GenRelNet and right is LDSDS GenRelNet. The points (nodes) in the pictures stand for
genes. Red points represent up-regulated genes; green points represent down-regulated genes. The lines stand for relationships of regulation,
solid line means positive correlation; long-dash line means negative correlation. Blue points is screened genes, yellow point is PSMD2.
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were elevated significantly (P = 0.007) in DHAS group com-
pared with LDSDS group. AQP7 (P = 0.038) and PSMD2
(P = 0.009) expression levels were significantly elevated in
DHAS group compared to LDSDS group (Figure 4).
Sensitivity and specificity of core genes of DHAS and
LDSDS for ZHENG differentiation
The levels of PNP, AQP7 and PSMD2 mRNA expressions
between DHAS and LDSDS were compared. As shown
in Figure 5, AUC of PNP, AQP7 and PSMD2 were 0.566
(P = 0.473, 95% CI, 0.372 to 0.761), 0.702 (P = 0.234, 95%Figure 3 Differential co-expression genes in DHAS and LDSDS. Sevent
ΔDegree≥ 5 were listed. Red bar, degrees of genes in DHAS GenRelNet; B
Δ degree which represents the degree difference of core genes in DHAS aCI, 0.426 to 0.794) and 0.767(P = 0.008, 95% CI, 0.587 to
0.900) respectively (Figure 5A).
Furthermore, we applied a stepwise logistic regression
model to combine the three core genes to distinguishing
DHAS from LDSDS. The predicted probability from the
logit model based on the three mRNA panel (PAP panel).
The logit model (P = LDSDS) = −0.634 + 13.701 PNP-
230.17 AQP7-512.468 PSMD2 was used to construct the
ROC-curve. The diagnostic performance for the estab-
lished mRNA panel was evaluated by using ROC analysis.
The AUC for the PAP panel was 0.835 (P = 0.000, 95% CI,
0.708 to 0.962, Figure 5B).een differential co-expression genes in DHAS and LDSDS with
lue bar, degrees of genes in LDSDS GenRelNet; Green line, the
nd LDSDS.
Table 3 Analysis of core genes in DHAS and LDSDS GeneRelNets (ΔDegree ≥ 8)
Gene Description Style DHAS degree LDSDS degree ΔDegree
PNP Purine nucleoside phosphorylase down 17 1 16
AQP7 Aquaporin 7 up 10 1 9
NFE2 Nuclear factor (erythroid-derived 2), 45 kDa down 13 4 9
PSMD2 Proteasome (prosome, macropain) 26S subunit,non-ATPase, 2 down 18 10 8
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in HBC
To further determine differential co-expression genes in
DHAS and LDSDS involved in the cellular behavior, we
conducted a GO enrichment analysis and searched for
functional categories.
The results showed that these differential co-expression
genes were enriched for neurological system process and
sensory perception in DHAS. By contrast, the functions
overrepresented by LDSDS samples related to the sensory
perception of smell, sensory perception of chemical stimu-
lus, response to stimulus, neurological system process,
and cognition, etc. Illustrative gene function diagrams cor-
responding to DHAS and LDSDS are given (Figure 6),
respectively.
Discussion
TCM ZHENG differs significantly in HBC patients [17].
DHAS and LDSDS are two typical TCM ZHENGs with
different clinical phenotype in HBC [8]. In TCM, DHAS
is recognized to dampness-heat accumulation. It repre-
sents accumulation of dampness-heat in the liver and
gallbladder resulting in impaired bile flow and down-
ward pouring of dampness-heat; LDSDS is recognized to
the dampness and heat accumulated in liver and gall-
bladder. It represents a syndrome marked by hypochon-
driac and abdominal painful distension, depressed mood,
frequent sighing, anorexia, uncomfortable loose bowels
or alleviation of abdominal pain after defecation, borbo-
rygmi with flatus and white slimy tongue coating, the same
as the syndrome of liver stagnation and spleen deficiency,
also known as the liver-spleen disharmony syndrome [18].Figure 4 mRNAs expression of PNP, AQP7 and PSMD2. PNP, AQP7 and
value of mRNA expressions were log 2-transformed with negative values seIt was the first time to stratify the DHAS and LDSDS of
HBC patients with the transcriptional technology.
Elucidating which genetic factors contribute to the
ZHENGs differentiation may have important therapeutic
implications in TCM practice. High-throughput, genome-
wide analytical technologies, especial expression microar-
rays could be both accurate and precise when properly
implemented. It has been used for disease classification
and identification of causal mechanisms in different
human liver diseases, such as alcoholic liver disease
[19], fatty liver disease [20], HCV-associated liver dis-
ease [21], liver cancer [22], and even liver tumor me-
tastases [23]. However, it is lack of microarray-based
diagnostic algorithm for ZHENG differentiation in HBC.
Since TCM is holistic and systems medicine [24], TCM
ZHENG differentiation may be demonstrated through the
investigation in gene regulated network. In this study, we
identified the whole gene expressions of DHAS and LDSDS
in HBC, and we found the significant difference in gene ex-
pression patterns between DHAS and LDSDS (Figure 1).
Moreover, we propose using co-expression-based gene
networks (GeneRelNets) to identify the biomarkers that
are associated with DHAS and LDSDS syndromes. In
GeneRelNets, the links between genes (nodes) were deter-
mined by the extent of their correlated pattern of ex-
pression across multiple genes and a variety of biological
relationships. Since the DHAS and LDSDS represent
the different ZHENGs of HBC, the GeneRelNets ana-
lysis showed the markedly different genes co-expressions
and their patterns (Figure 2), and there were differen-
tial co-expression genes (Figure 3). The degree centrality
difference of two GeneRelNets in DHAS and LDSDSPSMD2 mRNAs expression were tested by real time RT-PCR, and the
t to 1. DHAS, n = 20; LDSDS, n = 20. Mann–Whitney U test.
Figure 5 ROC curves for DHAS and LDSDS differentiation in HBC. ROC curves were generated using mRNA expression data with DHAS
(n = 20) and LDSDS (n = 20) in HBC. A, AUC of PNP, AQP7 and PSMD2 were 0.566, 0.610 and 0.744, respectively. B, AUC of mRNA panel of
combination of PNP, AQP7 and PSMD2 (PAP panel) was 0.835.
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LDSDS.
The differential co-expression genes of PNP, AQP7
and PSMD2 between DHAS and LDSDS were verified
(Figure 4) in another independent patient cohorts. To
observe the sensitivity and specificity of these mRNAs,
ROC curve analysis was conducted to differentiating DHAS
and LDSDS. The AUC of the three genes was 0.566, 0.372
and 0.702, respectively (Figure 5-A). The mRNA panel with
the three mRNAs from the multivariate logistic regressionFigure 6 GO enrichment analyses based on the differentially co-expre
biological process for differentially co-expressed genes of DHAS. B, GO cate
genes of LDSDS. - LgP is the base-10 logarithm of the p value.model demonstrated high accuracy (AUC= 0.835) in the
differentiation of DHAS and LDSDS (Figure 5-B). The re-
sult indicated that the three genes may be involved in
DHAS and LDSDS differentiation in HBC. PNP, a key en-
zyme in the purine salvage pathway, is located primarily in
the cytoplasm of endothelial cells, Kupffer cells, and hepa-
tocytes and is released into hepatic sinusoids during
necrosis [25] there are studies showed the value of PNP
as a marker of liver damage in rodents [26]. AQP7 are
transmembrane proteins that belong to the subset ofssed genes of DHAS and LDSDS. A, GO category based on the
gory based on the biological process for differentially co-expressed
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sulted in an increased accumulation of glycerol within the
adipocytes leading to adipocyte hypertrophy [27]. A large-
scale screening study [28] has been reported that PSMD2
offers a growth advantage to NIH3T3 cells under certain
conditions, which was known as a collagen-producing
fibroblast cell. Therefore, PSMD2 might be involved in the
generation of liver fibrosis. Epidemiological studies [29,30]
have reported that HBC develop to HCC often following
with TCM ZHENG changes from excess to deficiency. In
this study, AQP7 and PSMD2 expression in LDSDS was
significantly higher than that in DHAS. We speculated
that both HBC prognosis and HCC morbidity in LDSDS
patients may be more than that in DHAS patients. A fu-
ture study to elucidate how such molecular consequences
are mediated in PNP, AQP7 and PSMD2-involed relation-
ship between HBC and TCM ZHENG is warranted. It
indicated a possibility of distinguishing DHAS and LDSDS
by the expressions of PNP, AQP7 and PSMD2 their
combination.
Furthermore, we performed GO function enrichment
analysis to understand the different functions of DHAS
and LDSDS. The results indicated that there are similar-
ities of gene functions in DHAS and LDSDS, they all
mainly involved in system development, anatomical
structure development and so on. Otherwise, the DHAS
was most likely related to cellular process when the func-
tions overrepresented by LDSDS samples most related to
the response to stimulus (Figure 6). Previous studies
[31,32] showed that the central neurobiological mechanism
of LDSDS closely correlates to the hypothalamic-pituitary-
adrenal axis, brain-gut axis, myriad central neurotropic
factors, neurotransmitters and neuropeptides involving in
many encephalic regions such as the hypothalamus, hippo-
campus, cortex, amygdale, etc. This funding was consisting
with our GO analysis, which related to the chronic stress.
The limitations of this study are as follows. (1) A small
sample size limited the value and generalization of the
results; a larger population study should be further con-
sidered in both test group and validation group. (2) Only
two typical ZHENGs in HBC were discussed in this
study. Other ZHENGs types of HBC required for further
research. (3) Since the gene regulation network is com-
plicate and remaining unclear in HBV-caused chronic
diseases, the mechanism of selected genes needs further
study.
Conclusions
In this study, we demonstrated the transcriptional pro-
files, differential co-expression genes and their func-
tional properties for ZHENG differentiation in HBC
patients. The results suggested that there are particular
transcriptional profiles, genes co-expressions patterns
and their functional properties of DHAS and LDSDS,and several interesting genes including PNP, AQP7,
PSMD2 and their combination may be involved in
ZHENG differentiation of DHAS and LDSDS in HBC.
Although further investigation with larger number of
samples and other type ZHENGs is requested, these re-
sults supported the hypothesis that transcriptional pro-
files may be used to the ZHENG differentiation in HBC.
Additional file
Additional file 1: DEGs of DHAS and LDSDS.
Abbreviations
TCM: traditional Chinese medicine; HBC: hepatitis B-caused cirrhosis;
DHAS: dampness-heat accumulation syndrome; LDSDS: liver depression
and spleen deficiency syndrome; DEGs: differentially expressed genes;
GeneRelNet: Gene-Regulatory-Networks; PNP: purine nucleoside
phosphorylase; AQP7: aquaporin 7; PSMD2: proteasome 26S subunit,
non-ATPase 2; HBV: Chronic hepatitis B virus; HCC: hepatocellular carcinoma;
CHB: chronic hepatitis B; HBC: hepatitis B-caused cirrhosis; ALT: alanine
aminotransferase; AST: aspartate aminotransferase; AFP: Alpha Fetal Protein;
HA: Hyaluronic Acid; TBIL: total bilirubin; DBIL: direct bilirubin; GGT: gamma
glutamyl transferase; ALb: albumin; GO: Gene Ontology; ROC: Receiver-operator
characteristic.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
YYL, QLC and YG collected the samples, carried out the molecular genetic
studies, and drafted the manuscript. YYL and ZZG carried out the RT-PCR.
YYL, HZ and WZ participated in the design of the study and performed the
statistical analysis. YYH and SBS conceived of the study, and participated in
its design and coordination and helped to draft the manuscript. All authors
read and approved the final manuscript.
Acknowledgments
This study was supported by the National Science and Technology Major
Project of China (no. 2012ZX10005001-004 and no. 2009ZX09311-003). Key
Program of National Natural Science Fundation of China (81330084), and
E-Institutes of Shanghai Municipal Education Commission (no. E03008). The
“Yang Fan” Program of Shanghai Committee of science and Technology
Fund annotation (no. 14YF1411400).
Author details
1Research Center for Traditional Chinese Medicine Complexity System,
Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road,
Pudong, Shanghai 201203, China. 2Longhua Hospital, Shanghai University of
TCM, Shanghai 200126, China. 3Shuguang Hospital, Shanghai University of
TCM, Shanghai 201203, China.
Received: 14 October 2013 Accepted: 29 September 2014
Published: 3 October 2014
References
1. Lavanchy D: Hepatitis B virus epidemiology, disease burden, treatment,
and current and emerging prevention and control measures. J Viral
Hepat 2004, 11:97–107.
2. Liaw YF, Chu CM: Hepatitis B virus infection. Lancet 2009, 373:582–592.
3. Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP: The contributions
of hepatitis B virus and hepatitis C virus infections to cirrhosis and
primary liver cancer worldwide. J Hepatol 2006, 45:529–538.
4. Schütte K, Bornschein J, Malfertheiner P: Hepatocellular carcinoma–
epidemiological trends and risk factors. Dig Dis 2009, 27:80–92.
5. Su SB, Lu A, Li S, Jia W: Evidence-based ZHENG: a traditional Chinese
medicine syndrome. Evid base Compl Alternative Med 2012, 2012:246538.
http://www.hindawi.com/journals/ecam/2012/246538/.
Lu et al. BMC Complementary and Alternative Medicine 2014, 14:371 Page 9 of 9
http://www.biomedcentral.com/1472-6882/14/3716. Guo ZZ, Yu SH, Guan Y, Li YY, Lu YY, Zhang H, Su SB: Molecular
mechanisms of same TCM syndrome for different diseases and different
TCM syndrome for same disease in chronic hepatitis B and liver
cirrhosis. Evid base Compl Alternative Med 2012, 2012:120350. http://www.
hindawi.com/journals/ecam/2012/120350/.
7. Chen QL, Lu YY, Zhang GB, Song YN, Zhou Q-M, Zhang H, Zhang W, Su S-B:
Progression from excessive to deficient syndromes in chronic Hepatitis
B: a dynamical network analysis of miRNA array data. Evid base Compl
Alternative Med 2013, 2013:120350.
8. Zhang YX, Wei BH: Standard of clinic diagnosis, syndrome differentiation
and assessing curative effect on hepatocirrhosis. Chin J Integrated Trad
West Med Gastro-spleen 1994, 14:237–238.
9. Association CM: Chronic hepatitis B prevention and treatment guidelines.
Chinese J Infect Dis 2001, 19:56–62.
10. Zhao Y, Gou XJ, Dai JY, Peng JH, Feng Q, Sun SJ, Cao HJ, Zheng NN, Fang
JW, Jiang J, Su SB, Liu P, Hu YY, Zhang YY: Differences in metabolites of
different tongue coatings in patients with chronic hepatitis B. Evid base
Compl Alternative Med 2013, 2013:204908.
11. Sun SJ, Dai JY, Fang JW, Gou XJ, Cao HJ, Zheng NN, Wang Y, Zhang W,
Zhang YY, Jia W: Differences of excess and deficiency Zheng in patients
with chronic hepatitis B by urinary metabonomics. Evid base Compl
Alternative Med 2013, 2013:738245. http://www.hindawi.com/journals/ecam/
2013/738245/.
12. Gertler R, Rosenberg R, Fuehrer K, Dahm M, Nekarda H, Siewert JR:
Detection of circulating tumor cells in blood using an optimized
density gradient centrifugation. In Molecular Staging of Cancer.
Springer; 2003:149–155.
13. Pujana MA, Han JDJ, Starita LM, Stevens KN, Tewari M, Ahn JS, Rennert G,
Moreno V, Kirchhoff T, Gold B: Network modeling links breast cancer
susceptibility and centrosome dysfunction. Nat Genet 2007, 39:1338–1349.
14. Barabási AL, Oltvai ZN: Network biology: understanding the cell's
functional organization. Nat Rev Genet 2004, 5:101–113.
15. Ravasz E, Somera AL, Mongru DA, Oltvai ZN, Barabási A-L: Hierarchical
organization of modularity in metabolic networks. Science 2002,
297:1551–1555.
16. Carlson MR, Zhang B, Fang ZX, Mischel PS, Horvath S, Nelson SF: Gene
connectivity, function, and sequence conservation: predictions from
modular yeast co-expression networks. BMC Genomics 2006, 7:40.
17. Zhu LL, Meng H, Jiang J: Study on TCM syndrome typing of chronic
hepatitis B. Chin J Integrated Tradit West Med 2008, 28:20.
18. Organization WH: WHO international standard terminologies on
traditional medicine in the western pacific region. In Book WHO
international standard terminologies on traditional medicine in the western
pacific region (Editor ed.^eds.). City: City; 2007.
19. Deaciuc IV, Song ZY, McClain CJ: Lessons from large-scale gene profiling
of the liver in alcoholic liver disease. Hepatol Res 2005, 31:187–192.
20. Hoekstra M, Li Z, Kruijt JK, Eck MV, Berkel TJV, Kuiper J: The expression level
of non-alcoholic fatty liver disease-related gene PNPLA3 in hepatocytes
is highly influenced by hepatic lipid status. J Hepatol 2010, 52:244–251.
21. Branch AD, Walewski JL: The coming impact of gene expression profiling
on the diagnosis and treatment of HCV-associated liver disease.
Antiviral Res 2001, 52:173–179.
22. Kurokawa Y, Matoba R, Takemasa I, Nakamori S, Tsujie M, Nagano H, Dono
K, Umeshita K, Sakon M, Ueno N: Molecular features of non-B, non-C
hepatocellular carcinoma: a PCR-array gene expression profiling study.
J Hepatol 2003, 39:1004–1012.
23. Trolet J, Hupé P, Huon I, Lebigot I, Decraene C, Delattre O, Sastre-Garau X,
Saule S, Thiéry J-P, Plancher C: Genomic profiling and identification of
high-risk uveal melanoma by array CGH analysis of primary tumors and
liver metastases. Invest Ophthalmol Vis Sci 2009, 50:2572–2580.
24. Buriani A, Garcia Bermejo ML, Bosisio E, Xu Q, Li H, Dong X, Simmonds MSJ,
Carrara M, Tejedor N, Lucio-Cazana J, Hylands PJ: Omic techniques in
systems biology approaches to traditional Chinese medicine research:
Present and future. J Ethnopharmacol 2012, 140:535–544.
25. Ohuchi T, Tada K, Akamatsu K: Endogenous ET-1 contributes to liver injury
induced by galactosamine and endotoxin in isolated perfused rat liver.
Am J Physiol Gastrointest Liver Physiol 1995, 31:G997.
26. Ozer J, Ratner M, Shaw M, Bailey W, Schomaker S: The current state of
serum biomarkers of hepatotoxicity. Toxicology 2008, 245:194–205.
27. Hara-Chikuma M, Sohara E, Rai T, Ikawa M, Okabe M, Sasaki S, Uchida S,
Verkman A: Progressive adipocyte hypertrophy in aquaporin-7-deficientmice adipocyte glycerol permeability as a novel regulator of fat
accumulation. J Biol Chem 2005, 280:15493–15496.
28. Wan DF, Gong Y, Qin WX, Zhang PP, Li JJ, Wei L, Zhou XM, Li HN, Qiu XK,
Zhong F: Large-scale cDNA transfection screening for genes related to
cancer development and progression. Proc Natl Acad Sci U S A 2004,
101:15724–15729.
29. Yang CJ, Liu HW, Wang LC: Study on the differential gene expressions of
chronic hepatitis B patients of gan depression pi deficiency syndrome
and pi-wei damp-heat syndrome. Chin J Integrated Tradit West Med 2012,
32:1032–1037.
30. Liu SN, Tao XP, Wang RB: Study on Chinese syndromes developing rules
of chronic hepatitis B. Chin J Trad Med Sci Technol 2008, 3:002.
31. Li XH, Li JJ, Liu YY, Chen JX: Central neurobiological mechanism of liver
depression and spleen deficiency syndrome based on chronic stress:
a review. J Chinese Int Medicine 2012, 10:1.
32. Yue LF, Ding J, Chen JX, Yue GX, Liang Y, Huo SK, Li JJ: Establishment and
review of rat model of syndrome of liver depression with spleen
insufficiency. J Beijing University of Trad Chinese Med 2008, 6:396–400.
doi:10.1186/1472-6882-14-371
Cite this article as: Lu et al.: Study of ZHENG differentiation in Hepatitis
B-caused cirrhosis: a transcriptional profiling analysis. BMC
Complementary and Alternative Medicine 2014 14:371.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
